Pipamperone is a typical antipsychotic of the butyrophenone family used in the treatment of schizophrenia. It was developed by Janssen Pharmaceutica in 1961 and started its first round of clinical trials in 1963 .
...
Treatment of chronic psychoses and states of aggressiveness of various origins .
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.